In 2008, a patent application about a topical composition containing lysozyme, serratiopeptidase, Oscimum sanctum, and Azadirechta, for the prevention and/or treatment of mastitis and metritis in mammals, was filed [211]. The gene discussed is LYZ; the disease is mastitis.